U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT07516379) titled 'GRAfT 2.0. A Multimodal Prospective Approach to Define the Mechanisms and Clinical Features... Read More
U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT07517068) titled 'The Role of Acetazolamide in Mitigating Inflammation and Innate Immune Activation at High A... Read More
U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT07516977) titled 'Noseguard for Prevention of Respiratory Infections in Real-World Use' on April 01. Brief S... Read More
U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT07518420) titled 'Clinical Efficacy Evaluation of Chaizhi Hewei Decoction in the Treatment of Non-Erosive Ref... Read More
U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT07517861) titled 'Integrated Mental Health Nursing Program: Effects on Stigma, Cognitive Flexibility, and Cli... Read More
U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT07517744) titled 'Comparison Between Darbapoeitin Alpha and Roxadustat in CKD-related Anemia' on April 02. B... Read More
U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT07517185) titled 'The HIt HArd and hiT Early in Multiple Sclerosis Trial' on Nov. 21, 2025. Brief Summary: T... Read More
U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT07518251) titled 'CompaRison of FEmorofemoral Bypass and Left-Heart ByPass Techniques in Open Thoracoabdomina... Read More
U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT07518641) titled 'Feasibility of the TransitionED Framework for Youth and Young Adults With Eating Disorders'... Read More
U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT07518186) titled 'A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory ... Read More